Telocapil Uses, Dosage, Side Effects and more
Telocapil is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus).
| Attribute | Details |
|---|---|
| Trade Name | Telocapil |
| Generic | Dihydromyricetin |
| Dihydromyricetin Other Names | (+)-ampelopsin, (+)-dihydromyricetin, Ampelopsin, Ampeloptin, Telocapil |
| Type | |
| Formula | C15H12O8 |
| Weight | Average: 320.251 Monoisotopic: 320.05321736 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
